Cargando…

Facilitating Collaborations to Develop Combination Investigational Cancer Therapies : Workshop Summary /

"Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.). Board on Health Care Services
Otros Autores: Patlak, Margie, Nass, Sharyl J., Balogh, Erin
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2012.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn785373830
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 120411s2012 dcua ob 100 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d IDEBK  |d NTE  |d CDX  |d YDXCP  |d OCLCQ  |d OCLCF  |d DKDLA  |d OCLCQ  |d OCLCO  |d OCLCQ  |d CIT  |d MMU  |d UCNAP  |d E7B  |d UKMGB  |d OCLCQ  |d OCL  |d OCLCO  |d EBLCP  |d OCLCO  |d OCLCQ  |d OCLCO  |d NKT  |d TOA  |d AGLDB  |d ZCU  |d OCLCQ  |d MERUC  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d BUF  |d OCLCO  |d VT2  |d OCLCO  |d VNS  |d VTS  |d UAB  |d ICG  |d MERER  |d REC  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d LVT  |d OCLCA  |d S9I  |d STF  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d OCLCQ  |d OCLCA  |d UKAHL  |d OCLCA  |d AJS  |d OCLCQ  |d OCLCO  |d SFB  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |a 016092846  |2 Uk 
019 |a 776753580  |a 785337634  |a 794491570  |a 817067884  |a 824114298  |a 847597145  |a 923289118  |a 1021256324  |a 1028770976  |a 1048167185  |a 1055312373  |a 1065825798  |a 1081246063  |a 1156373622  |a 1204378352  |a 1204379712  |a 1228611923  |a 1249235957 
020 |a 9780309220651  |q (electronic bk.) 
020 |a 0309220653  |q (electronic bk.) 
020 |a 1280123346 
020 |a 9781280123344 
020 |z 9780309220644 
020 |z 0309220645 
029 1 |a AU@  |b 000051482375 
029 1 |a DEBBG  |b BV042794605 
029 1 |a DEBBG  |b BV044109376 
029 1 |a DEBSZ  |b 421432373 
029 1 |a GBVCP  |b 803955936 
029 1 |a NZ1  |b 14973780 
029 1 |a AU@  |b 000054187296 
035 |a (OCoLC)785373830  |z (OCoLC)776753580  |z (OCoLC)785337634  |z (OCoLC)794491570  |z (OCoLC)817067884  |z (OCoLC)824114298  |z (OCoLC)847597145  |z (OCoLC)923289118  |z (OCoLC)1021256324  |z (OCoLC)1028770976  |z (OCoLC)1048167185  |z (OCoLC)1055312373  |z (OCoLC)1065825798  |z (OCoLC)1081246063  |z (OCoLC)1156373622  |z (OCoLC)1204378352  |z (OCoLC)1204379712  |z (OCoLC)1228611923  |z (OCoLC)1249235957 
043 |a n-us--- 
050 4 |a RC268 
060 4 |a QZ 267 
072 7 |a HEA  |x 039030  |2 bisacsh 
072 7 |a MED  |x 062000  |2 bisacsh 
082 0 4 |a 616.99/405  |2 23 
049 |a UAMI 
110 2 |a National Cancer Policy Forum (U.S.) 
245 1 0 |a Facilitating Collaborations to Develop Combination Investigational Cancer Therapies :  |b Workshop Summary /  |c Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c ©2012. 
300 |a 1 online resource (xiii, 103 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
500 |a Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C. 
504 |a Includes bibliographical references (pages 97-99). 
520 |a "Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description 
588 0 |a Print version record. 
505 0 |a Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Cancer  |x Research  |z United States  |v Congresses. 
650 0 |a Cancer  |x Treatment  |v Congresses. 
650 0 |a Cancer  |z United States  |x Prevention  |v Congresses. 
650 0 |a Health planning  |z United States  |v Congresses. 
650 1 2 |a Neoplasms  |x drug therapy 
650 1 2 |a Drug Therapy, Combination 
650 2 2 |a Antineoplastic Agents  |x therapeutic use 
650 2 2 |a Cooperative Behavior 
651 2 |a United States 
650 6 |a Cancer  |x Recherche  |z États-Unis  |v Congrès. 
650 6 |a Cancer  |x Traitement  |v Congrès. 
650 6 |a Cancer  |z États-Unis  |x Prévention  |v Congrès. 
650 6 |a Santé publique  |x Planification  |z États-Unis  |v Congrès. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a Cancer  |x Prevention  |2 fast 
650 7 |a Cancer  |x Research  |2 fast 
650 7 |a Cancer  |x Treatment  |2 fast 
650 7 |a Health planning  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Patlak, Margie. 
700 1 |a Nass, Sharyl J. 
700 1 |a Balogh, Erin. 
710 2 |a National Cancer Policy Forum (U.S.) 
710 2 |a Institute of Medicine (U.S.).  |b Board on Health Care Services. 
758 |i has work:  |a Facilitating Collaborations to Develop Combination Investigational Cancer Therapies (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGPFc7Vc4gw6TpyQM6Bqw3  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Facilitating Collaborations to Develop Combination Investigational Cancer Therapies (2011 : Washington, D.C.).  |t Facilitating Collaborations to Develop Combination Investigational Cancer Therapies.  |d Washington, D.C. : National Academies Press, ©2012  |z 9780309220644  |w (DLC) 2011278592  |w (OCoLC)778637018 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378946  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36559688 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36617487 
938 |a Coutts Information Services  |b COUT  |n 21789456 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3378946 
938 |a ebrary  |b EBRY  |n ebr10554791 
938 |a EBSCOhost  |b EBSC  |n 444959 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 352720 
938 |a YBP Library Services  |b YANK  |n 7608234 
994 |a 92  |b IZTAP